Vegetarians have lower cardiovascular risk

A British study has shown that vegans have a 32% lower risk of suffering from vascular diseases. The trial that included 45,000 men and women stated that vegans also have lower risk of developing diabetes and lower MBI (max body index) which signals overweight and obesity. 

Results also show the importance of eating habits in preventing heart disease. Low cardiovascular risk for vegans results from a study carried out by a team of Oxford University, in Great Britain.

Researchers considered 44,561 men and women living in England and Scotland. From this population, 34 per cent had a vegan diet. After an 11 year follow up, it was determined that vegans have a 32% lower MI risk. This was independent from factors such as sex, age, obesity and others. This study was probably due to differences in cholesterol and arterial pressure. Vegans not only benefit from the positive impact of a lower BMI, but also benefit from a 28% heart disease risk reduction. 

Source

SOLACI.ORG

More articles by this author

Women Present Lower Risk of Sport Related Sudden Death Compared to Men

According to this recent analysis published in Eur Heart J, women would have a far lower chances of dying suddenly for physical exertion during...

Saturated Fats: Dietary Angels or Demons?

In order to reduce cardiovascular events, dietary guidelines recommend restricting saturated fatty acids—without taking into account differences among them—to <10% of the daily caloric...

Low-Carb Diet and Coronary Artery Calcium Progression

People on low carb diets since a young age present increased risk of coronary artery calcium progression, particularly when carbs are replaced by animal...

Number of Hours of Sleep and Risk of Stroke

Sleep duration (either short or long) affect the risk of stroke according to this recent analysis. We had visited a study published in JACC...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...